Follow-up study for measles maternal antibodies and seroconversion after measles vaccination

Area of Science:

• Pediatrics
• Immunology
• Infectious Diseases

Background:

• Maternal measles antibodies wane in infants, potentially leaving them susceptible to infection.
• Assessing infant measles immunity is crucial for timely vaccination strategies.

Purpose of the Study:

• To evaluate measles maternal antibody levels and susceptibility in infants at six and nine months.
• To determine the seroconversion rates following primary measles vaccination at nine months and revaccination at fifteen months.

Main Methods:

• Study included 72 children, assessing measles IgG levels at six and nine months.
• Seroconversion was evaluated after measles vaccination at nine months and revaccination at fifteen months.

Main Results:

• 33% of infants at six months and 36% at nine months showed negative measles antibody tests, indicating susceptibility.
• No significant difference in measles IgG levels was observed between six and nine months.
• An 85% seroconversion rate was achieved after the first measles vaccination at nine months.
• Revaccination at fifteen months led to a significant increase in measles IgG levels.

Conclusions:

• A notable proportion of infants remain susceptible to measles at nine months of age.
• Measles vaccination at nine months is effective in inducing seroconversion, but a booster at fifteen months further enhances immunity.